Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16179020rdf:typepubmed:Citationlld:pubmed
pubmed-article:16179020lifeskim:mentionsumls-concept:C0019169lld:lifeskim
pubmed-article:16179020lifeskim:mentionsumls-concept:C0037140lld:lifeskim
pubmed-article:16179020lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:16179020lifeskim:mentionsumls-concept:C0596402lld:lifeskim
pubmed-article:16179020lifeskim:mentionsumls-concept:C1842211lld:lifeskim
pubmed-article:16179020lifeskim:mentionsumls-concept:C0205296lld:lifeskim
pubmed-article:16179020pubmed:issue3lld:pubmed
pubmed-article:16179020pubmed:dateCreated2005-9-23lld:pubmed
pubmed-article:16179020pubmed:abstractTextNatural killer (NK) cells represent the first line of defence against viral infections but, in the case of hepatitis B virus (HBV), may also be involved in liver injury. We here compared NK-cell activity of 11 patients with acute HBV infection, either HIV-positive or HIV-negative, with that of 11 healthy subjects. One of the HIV-positive patients, characterized by a severe immunodeficiency, died 3 weeks after hospitalization for HBV-related fulminant hepatitis (FH). He displayed a remarkable NK-cell cytotoxicity against both cell lines and autologous dendritic cells, whereas the NK-cell activity of the remaining patients was significantly reduced as compared with healthy individuals. Our findings suggest that NK-cell-mediated cytotoxicity could contribute to the development of HBV-related acute liver failure in HIV-positive patients with severe immunodeficiency. An immunopathological model of FH in immunocompromised patients was proposed.lld:pubmed
pubmed-article:16179020pubmed:languageenglld:pubmed
pubmed-article:16179020pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16179020pubmed:citationSubsetIMlld:pubmed
pubmed-article:16179020pubmed:statusMEDLINElld:pubmed
pubmed-article:16179020pubmed:monthSeplld:pubmed
pubmed-article:16179020pubmed:issn0300-9475lld:pubmed
pubmed-article:16179020pubmed:authorpubmed-author:MarinelliMMlld:pubmed
pubmed-article:16179020pubmed:authorpubmed-author:GalliAAlld:pubmed
pubmed-article:16179020pubmed:authorpubmed-author:LazzarinAAlld:pubmed
pubmed-article:16179020pubmed:authorpubmed-author:FortinFFlld:pubmed
pubmed-article:16179020pubmed:authorpubmed-author:MorsicaGGlld:pubmed
pubmed-article:16179020pubmed:authorpubmed-author:BiswasPPlld:pubmed
pubmed-article:16179020pubmed:authorpubmed-author:PatiesCClld:pubmed
pubmed-article:16179020pubmed:authorpubmed-author:MalnatiMMlld:pubmed
pubmed-article:16179020pubmed:authorpubmed-author:TascaSSlld:pubmed
pubmed-article:16179020pubmed:authorpubmed-author:BagaglioSSlld:pubmed
pubmed-article:16179020pubmed:issnTypePrintlld:pubmed
pubmed-article:16179020pubmed:volume62lld:pubmed
pubmed-article:16179020pubmed:ownerNLMlld:pubmed
pubmed-article:16179020pubmed:authorsCompleteYlld:pubmed
pubmed-article:16179020pubmed:pagination318-24lld:pubmed
pubmed-article:16179020pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16179020pubmed:meshHeadingpubmed-meshheading:16179020...lld:pubmed
pubmed-article:16179020pubmed:meshHeadingpubmed-meshheading:16179020...lld:pubmed
pubmed-article:16179020pubmed:meshHeadingpubmed-meshheading:16179020...lld:pubmed
pubmed-article:16179020pubmed:meshHeadingpubmed-meshheading:16179020...lld:pubmed
pubmed-article:16179020pubmed:meshHeadingpubmed-meshheading:16179020...lld:pubmed
pubmed-article:16179020pubmed:meshHeadingpubmed-meshheading:16179020...lld:pubmed
pubmed-article:16179020pubmed:meshHeadingpubmed-meshheading:16179020...lld:pubmed
pubmed-article:16179020pubmed:meshHeadingpubmed-meshheading:16179020...lld:pubmed
pubmed-article:16179020pubmed:meshHeadingpubmed-meshheading:16179020...lld:pubmed
pubmed-article:16179020pubmed:meshHeadingpubmed-meshheading:16179020...lld:pubmed
pubmed-article:16179020pubmed:meshHeadingpubmed-meshheading:16179020...lld:pubmed
pubmed-article:16179020pubmed:meshHeadingpubmed-meshheading:16179020...lld:pubmed
pubmed-article:16179020pubmed:meshHeadingpubmed-meshheading:16179020...lld:pubmed
pubmed-article:16179020pubmed:year2005lld:pubmed
pubmed-article:16179020pubmed:articleTitleNatural killer-cell cytotoxicity in HIV-positive and HIV-negative patients with and without severe course of hepatitis B virus infection.lld:pubmed
pubmed-article:16179020pubmed:affiliationLaboratory of Clinical Immunology, Clinic of Infectious Diseases, San Raffaele Scientific Institute and Vita-Saltue San Raffaele University, School of Medicine, Milan, Italy.lld:pubmed
pubmed-article:16179020pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16179020pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16179020lld:pubmed